Levels of VEGF but not VEGF165b are increased in the vitreous of patients with retinal vein occlusion

American Journal of Ophthalmology

Volumn 152, Issue 2, 2011, Pages

  Ehlken, Christoph ^a   Rennel, Emma S ^b   Michels, Daniel ^a   Grundel, Bastian ^a   Pielen, Amelie ^a   Junker, Bernd ^a   Stahl, Andreas ^a   Hansen, Lutz L ^a   Feltgen, Nicolas ^c   Agostini, Hansjrgen T ^a   Martin, Gottfried ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Universittsklinikum Göttingen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN 165;

ADULT; AGED; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; FEMALE; HUMAN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RADIAL OPTIC NEUROTOMY; RETINA MACULA HOLE; REVIEW; VITREOUS BODY;

EID: 80955180589     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.01.040     Document Type: Article

References (40)

1. S.S. Hayreh, M.B. Zimmerman, and P. Podhajsky Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics Am J Ophthalmol 117 4 1994 429 441 (Pubitemid 24115701)
2. Argon laser photocoagulation for macular edema in branch vein occlusion The Branch Vein Occlusion Study Group Am J Ophthalmol 98 3 1984 271 282
3. S.L. Rogers, R.L. McIntosh, and L. Lim Natural history of branch retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 6 2010 1094 1101 e5
4. R.L. McIntosh, S.L. Rogers, and L. Lim Natural history of central retinal vein occlusion: an evidence-based systematic review Ophthalmology 117 6 2010 1113 1123 e15
5. H. Noma, H. Funatsu, T. Mimura, S. Eguchi, and K. Shimada Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series BMC Ophthalmol 10 2010 11
6. F. Prager, S. Michels, and K. Kriechbaum Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial Br J Ophthalmol 93 4 2009 452 456
7. L. Wu, J.F. Arevalo, and M.H. Berrocal Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months Retina 29 10 2009 1396 1403
8. A. Stahl, I. Struebin, L.L. Hansen, H.T. Agostini, and N. Feltgen Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment Eur J Ophthalmol 20 1 2010 180 185
9. G.B. Jaissle, M. Leitritz, and F. Gelisken One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 247 1 2009 27 33
10. K. Kriechbaum, S. Michels, and F. Prager Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study Br J Ophthalmol 92 4 2008 518 522 (Pubitemid 351497981)
11. M.D. Rabena, D.J. Pieramici, A.A. Castellarin, M.A. Nasir, and R.L. Avery Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion Retina 27 4 2007 419 425 (Pubitemid 46624280)
12. T.C. Kreutzer, C.S. Alge, and A.H. Wolf Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion Br J Ophthalmol 92 3 2008 351 355 (Pubitemid 351363529)
13. A. Stahl, H. Agostini, L.L. Hansen, and N. Feltgen Bevacizumab in retinal vein occlusion-results of a prospective case series Graefes Arch Clin Exp Ophthalmol 245 10 2007 1429 1436 (Pubitemid 47423323)
14. R.A. Costa, R. Jorge, and D. Calucci Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study Retina 27 2 2007 141 149
15. A.E. Hoeh, T. Ach, K.B. Schaal, A.F. Scheuerle, and S. Dithmar Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 247 12 2009 1635 1641
16. M. Kondo, N. Kondo, and Y. Ito Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12 months and multiple regression analysis Retina 29 9 2009 1242 1248
17. P.A. Campochiaro, G. Hafiz, and S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 4 2008 791 799 (Pubitemid 351426182)
18. A. Rouvas, P. Petrou, and A. Ntouraki Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study Retina 30 6 2010 893 902
19. R.F. Spaide, L.K. Chang, and J.M. Klancnik Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion Am J Ophthalmol 147 2 2009 298 306
20. T.A. Ciulla, and P.J. Rosenfeld Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration Curr Opin Ophthalmol 20 3 2009 158 165
21. N. Feltgen, A. Pielen, and L. Hansen [Intravitreal drug therapy for retinal vein occlusionpathophysiological mechanisms and routinely used drugs] Klin Monbl Augenheilkd 227 9 2010 681 693
22. S.J. Harper, and D.O. Bates VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8 11 2008 880 887
23. B. Zhang, Y. Hu, and J. Ma Anti-inflammatory and antioxidant effects of SERPINA3K in the retina Invest Ophthalmol Vis Sci 50 8 2009 3943 3952
24. R.M. Perrin, O. Konopatskaya, and Y. Qiu Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor Diabetologia 48 11 2005 2422 2427 (Pubitemid 41618935)
25. H. Noma, H. Funatsu, T. Mimura, S. Harino, and S. Hori Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion Ophthalmology 116 1 2009 87 93
26. M. Shimura, T. Nakazawa, and K. Yasuda Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema Acta Ophthalmol 86 4 2008 377 384
27. A.I. Saeed, V. Sharov, and J. White TM4: a free, open-source system for microarray data management and analysis BioTechniques 34 2 2003 374 378 (Pubitemid 36184095)
28. J. Woolard, W. Wang, and H.S. Bevan VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression Cancer Res 64 21 2004 7822 7835 (Pubitemid 39446915)
29. P.K. Smith, R.I. Krohn, and G.T. Hermanson Measurement of protein using bicinchoninic acid Anal Biochem 150 1 1985 76 85 (Pubitemid 16258399)
30. L.P. Aiello, R.L. Avery, and P.G. Arrigg Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 22 1994 1480 1487 (Pubitemid 24356306)
31. R.M. Silva, J.R. Faria de Abreu, and J.G. Cunha-Vaz Blood-retina barrier in acute retinal branch vein occlusion Graefes Arch Clin Exp Ophthalmol 233 11 1995 721 726
32. H. Noma, A. Minamoto, and H. Funatsu Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 244 3 2006 309 315
33. A. Stahl, A. Buchwald, and G. Martin Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema Retina 30 9 2010 1524 1529
34. A.L. Magnussen, E.S. Rennel, and J. Hua VEGF-A165b is cytoprotective and antiangiogenic in the retina Invest Ophthalmol Vis Sci 51 8 2010 4273 4281
35. J. Hua, C. Spee, and S. Kase Recombinant human VEGF165b inhibits experimental choroidal neovascularization Invest Ophthalmol Vis Sci 51 8 2010 4282 4288
36. E. Rennel, E. Waine, and H. Guan The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice Br J Cancer 98 7 2008 1250 1257 (Pubitemid 351481687)
37. O. Konopatskaya, A.J. Churchill, S.J. Harper, D.O. Bates, and T.A. Gardiner VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice Mol Vis 12 2006 626 632 (Pubitemid 43786776)
38. D.G. Nowak, J. Woolard, and E.M. Amin Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors J Cell Sci 121 Pt 20 2008 3487 3495
39. D.G. Nowak, E.M. Amin, and E.S. Rennel Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis J Biol Chem 285 8 2010 5532 5540
40. Y. Inomata, A. Hirata, and E. Takahashi Elevated erythropoietin in vitreous with ischemic retinal diseases Neuroreport 15 5 2004 877 879 (Pubitemid 38453478)